Literature DB >> 29654395

The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.

Melahat Coban1, Ayca Inci2.   

Abstract

PURPOSE: Autosomal dominant polycystic kidney disease (ADPKD) is a common congenital chronic kidney disease (CKD). We report here the relationship of serum angiopoietin-1 (Ang-1), Ang-2, and vascular endothelial growth factor (VEGF) with total kidney volume (TKV), total cyst volume (TCV), and renal failure in adult ADPKD patients at various stages of CKD.
METHODS: This cross-sectional study was conducted with 50 patients diagnosed with ADPKD and a control group of 45 age-matched healthy volunteers. In patient group, TKV and TCV were determined with upper abdominal magnetic resonance imaging, whereas in controls, TKV was determined with ultrasonography according to ellipsoid formula. Renal function was assessed with serum creatinine, estimated glomerular filtration rate (eGFR), and spot urinary protein/creatinine ratio (UPCR). Ang-1, Ang-2, and VEGF were measured using enzyme-linked immunosorbent assay.
RESULTS: Patients with ADPKD had significantly higher TKV (p < 0.001) and UPCR (p < 0.001), and lower eGFR (p ≤ 0.001) compared to the controls. Log10Ang-2 was found to be higher in ADPKD patients at all CKD stages. Multiple linear regression analysis showed that there was no association between log10Ang-1, log10Ang-2, or log10VEGF and creatinine, eGFR, UPCR, log10TKV (p > 0.05).
CONCLUSION: There was no association of serum angiogenic growth factors with TKV or renal failure in ADPKD patients. Increased serum Ang-2 observed in stages 1-2 CKD suggests that angiogenesis plays a role in the progression of early stage ADPKD, but not at later stages of the disease. This may be explained by possible cessation of angiogenesis in advanced stages of CKD due to the increased number of sclerotic glomeruli.

Entities:  

Keywords:  Angiopoietin; Autosomal dominant polycystic kidney disease; Renal failure; Total kidney volume; Vascular endothelial growth factor

Mesh:

Substances:

Year:  2018        PMID: 29654395     DOI: 10.1007/s11255-018-1866-1

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  38 in total

1.  Renal volume measurements: accuracy and repeatability of US compared with that of MR imaging.

Authors:  J Bakker; M Olree; R Kaatee; E E de Lange; K G Moons; J J Beutler; F J Beek
Journal:  Radiology       Date:  1999-06       Impact factor: 11.105

2.  Anti-VEGF antibody treatment accelerates polycystic kidney disease.

Authors:  Shagun Raina; Michael Honer; Stefanie D Krämer; Yang Liu; Xueqi Wang; Stephan Segerer; Rudolf P Wüthrich; Andreas L Serra
Journal:  Am J Physiol Renal Physiol       Date:  2011-06-15

3.  Circulating angiopoietin-2 levels increase with progress of chronic kidney disease.

Authors:  Sascha David; Philipp Kümpers; Alexander Lukasz; Danilo Fliser; Jens Martens-Lobenhoffer; Stefanie M Bode-Böger; Volker Kliem; Hermann Haller; Jan T Kielstein
Journal:  Nephrol Dial Transplant       Date:  2010-02-22       Impact factor: 5.992

4.  Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis.

Authors:  Hoong Sern Lim; Gregory Y H Lip; Andrew D Blann
Journal:  Atherosclerosis       Date:  2004-12-21       Impact factor: 5.162

5.  Angiogenic growth factors correlate with disease severity in young patients with autosomal dominant polycystic kidney disease.

Authors:  Berenice Y Reed; Amirali Masoumi; Elwaleed Elhassan; Kim McFann; Melissa A Cadnapaphornchai; David M Maahs; Janet K Snell-Bergeon; Robert W Schrier
Journal:  Kidney Int       Date:  2010-09-29       Impact factor: 10.612

6.  VEGF(165) mediates glomerular endothelial repair.

Authors:  T Ostendorf; U Kunter; F Eitner; A Loos; H Regele; D Kerjaschki; D D Henninger; N Janjic; J Floege
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

7.  VEGF receptor inhibition blocks liver cyst growth in pkd2(WS25/-) mice.

Authors:  Claudia R Amura; Kelley S Brodsky; Rachel Groff; Vincent H Gattone; Norbert F Voelkel; R Brian Doctor
Journal:  Am J Physiol Cell Physiol       Date:  2007-05-02       Impact factor: 4.249

8.  Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid.

Authors:  Matthew T Nichols; Elsa Gidey; Tom Matzakos; Rolf Dahl; Greg Stiegmann; Raj J Shah; Jared J Grantham; J Gregory Fitz; R Brian Doctor
Journal:  Hepatology       Date:  2004-10       Impact factor: 17.425

9.  Liver cysts in autosomal-dominant polycystic kidney disease: clinical and computed tomographic study.

Authors:  E Levine; L T Cook; J J Grantham
Journal:  AJR Am J Roentgenol       Date:  1985-08       Impact factor: 3.959

10.  Angiopoietin-2 is associated with albuminuria and microinflammation in chronic kidney disease.

Authors:  Fan-Chi Chang; Tai-Shuan Lai; Chih-Kang Chiang; Yung-Ming Chen; Ming-Shiou Wu; Tzong-Shinn Chu; Kwan-Dun Wu; Shuei-Liong Lin
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

View more
  1 in total

1.  Regression of Peritubular Capillaries Coincides with Angiogenesis and Renal Cyst Growth in Experimental Polycystic Kidney Disease.

Authors:  Kristal O'Brien; Sayanthooran Saravanabavan; Jennifer Q J Zhang; Annette T Y Wong; Alexandra Munt; Jane S Burgess; Gopala K Rangan
Journal:  Int J Nephrol Renovasc Dis       Date:  2020-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.